Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127159062 | 12715906 | 2 | F | 20160801 | 20160913 | 20160906 | 20160921 | EXP | NL-ASTRAZENECA-2016SE94384 | ASTRAZENECA | 29662.00 | DY | M | Y | 0.00000 | 20160921 | OT | NL | NL |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127159062 | 12715906 | 1 | PS | ZOLADEX | GOSERELIN ACETATE | 1 | Subcutaneous | 10.8MG UNKNOWN | U | KC455,MF032,LT650 | 20578 | 10.8 | MG | IMPLANT |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127159062 | 12715906 | 1 | Prostate cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127159062 | 12715906 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127159062 | 12715906 | Malignant neoplasm progression |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |